BBC vs. SURI ETF Comparison
Comparison of Virtus LifeSci Biotech Clinical Trials ETF (BBC) to Simplify Exchange Traded Funds Simplify Propel Opportunities ETF (SURI)
BBC
Virtus LifeSci Biotech Clinical Trials ETF
BBC Description
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.
Grade (RS Rating)
Last Trade
$26.09
Average Daily Volume
4,123
Number of Holdings
*
90
* may have additional holdings in another (foreign) market
SURI
Simplify Exchange Traded Funds Simplify Propel Opportunities ETF
SURI Description
The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The fund is non-diversified.Grade (RS Rating)
Last Trade
$21.70
Average Daily Volume
19,878
Number of Holdings
*
10
* may have additional holdings in another (foreign) market
Performance
Period | BBC | SURI |
---|---|---|
30 Days | -10.43% | -14.92% |
60 Days | -16.77% | -16.02% |
90 Days | 2.80% | 6.03% |
12 Months | 10.76% | 10.00% |
BBC Overweight 86 Positions Relative to SURI
Symbol | Grade | Weight | |
---|---|---|---|
ALPN | A | 2.89% | |
VKTX | B | 2.86% | |
VERA | D | 2.27% | |
DYN | C | 1.82% | |
SANA | C | 1.72% | |
CGEM | A | 1.66% | |
CYTK | D | 1.52% | |
LQDA | D | 1.5% | |
MGNX | D | 1.48% | |
KROS | D | 1.38% | |
MRUS | C | 1.37% | |
NRIX | D | 1.34% | |
GERN | A | 1.34% | |
KURA | C | 1.33% | |
IOVA | C | 1.3% | |
BCYC | C | 1.28% | |
FDMT | D | 1.26% | |
COGT | F | 1.19% | |
KYMR | D | 1.19% | |
SMMT | C | 1.19% | |
KRYS | D | 1.18% | |
MLYS | C | 1.17% | |
RVMD | A | 1.17% | |
PTGX | D | 1.09% | |
CRNX | A | 1.07% | |
INBX | D | 1.05% | |
ALLO | F | 1.05% | |
LYEL | D | 1.02% | |
IGMS | D | 1.0% | |
DAWN | A | 0.99% | |
ALXO | A | 0.99% | |
IDYA | C | 0.97% | |
PGEN | F | 0.94% | |
ARDX | D | 0.93% | |
ACLX | D | 0.9% | |
IMTX | F | 0.9% | |
CMPS | C | 0.9% | |
SNDX | C | 0.89% | |
CLDX | D | 0.88% | |
ITOS | D | 0.86% | |
PCVX | D | 0.85% | |
ANAB | B | 0.85% | |
ARCT | F | 0.84% | |
XENE | C | 0.84% | |
MORF | F | 0.82% | |
ARVN | D | 0.81% | |
ORIC | D | 0.81% | |
RCUS | D | 0.74% | |
DVAX | F | 0.73% | |
XNCR | C | 0.73% | |
NUVL | C | 0.72% | |
BLTE | C | 0.71% | |
RCKT | F | 0.71% | |
ZNTL | F | 0.71% | |
REPL | F | 0.7% | |
ETNB | F | 0.7% | |
ARWR | F | 0.7% | |
OLMA | D | 0.69% | |
RXRX | D | 0.68% | |
VIR | F | 0.68% | |
BEAM | F | 0.67% | |
TGTX | D | 0.67% | |
SRRK | C | 0.67% | |
BMEA | F | 0.66% | |
RGNX | F | 0.65% | |
PLRX | F | 0.63% | |
NVAX | F | 0.62% | |
VRDN | F | 0.62% | |
TERN | F | 0.61% | |
ABCL | F | 0.61% | |
DNLI | F | 0.59% | |
SAVA | B | 0.58% | |
IMVT | F | 0.57% | |
NTLA | D | 0.57% | |
ALEC | F | 0.56% | |
CRBU | F | 0.55% | |
CABA | F | 0.55% | |
QURE | F | 0.5% | |
RLAY | D | 0.5% | |
PRTA | F | 0.45% | |
EDIT | F | 0.43% | |
VERV | F | 0.41% | |
IRON | F | 0.39% | |
CVAC | F | 0.38% | |
RAPT | F | 0.35% | |
ALLK | F | 0.28% |
BBC: Top Represented Industries & Keywords
SURI: Top Represented Industries & Keywords
Industries:
Biotechnology
Oil & Gas Midstream
Keywords:
Biopharmaceutical
Life Sciences
Biotechnology
Cancer
Disease
Disorders
Medication
Medicine
Metabolic Disease
Acid
Alcohol
Betashares
Biopharmaceutical Products
Brain Disorders
Cardiomyopathy
Cardiovascular And Metabolic Diseases
Cardiovascular Disease
Chemical Substances
Cholesterol
Clinical Trial